Therefore, in the present study, serum IL-6 was measured by enzymelinked immunosorbent assay (ELISA) kits and its relationship withclinical symptoms, such as depressive symptoms and pain levels,was also determined in BMS patients. This evidence concerns the gene IL6 and burning mouth syndrome.